InsidersTradesSigma
Discover the complete record of transactions filed by Hunder Naomi, Directeur Médical. Insider active across 1 company, notably Silverback Therapeutics, Inc.. Aggregated, 3 disclosures have been published. Activity tracked since 1 February 2022. The latest transaction was filed on 2 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations
Hunder Naomi serves as Chief Medical Officer for Silverback Therapeutics, Inc. In this role, she oversees the company's medical initiatives and research programs. Her expertise in medicine and biotechnology is essential for developing innovative treatments. Hunder is committed to improving patient health through advanced therapeutic solutions.